DATAGUARD
5.6.2024 17:29:34 CEST | Business Wire | Press release
DataGuard, a leading Software-as-a-Service (SaaS) company for security and compliance, announced today that it has acquired DPOrganizer. This acquisition expands DataGuard’s footprint particularly in the Nordic region and the UK, and strengthens the company’s market position across its core geographies Europe and North America. DataGuard helps over 4,000 customers active in more than 50 countries build robust security and compliance management systems. Companies use DataGuard’s software platform to get certified and become compliant with frameworks (such as GDPR, CCPA, ISO 27001, NIS 2, or SOC 2) as well as manage their most important risks efficiently, thereby staying ahead of evolving business and regulatory needs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240605633259/en/
Security & Compliance Management Software (Photo: Business Wire)
DPOrganizer, a Stockholm-based privacy management solution for privacy professionals and in-house data protection and compliance teams, helps small and large customers in more than 20 countries build and run effective privacy programs, comply with regulation, and build trust with their customers and partners. DPOrganizer’s powerful software toolkit offers incidents and breach management, data subject request handling, data protection impact assessments, and more functionalities. Thanks to the advanced data mapping, analytics and data flow visualization capabilities, data protection officers and privacy professionals can ensure collection and retention of data in line with regulation and best practice, identifying patterns and anomalies, and preventing breaches or non-compliance.
"Today’s announcement is a major milestone on DataGuard’s growth journey. Integrating DPOrganizer’s capabilities will enhance our offering for customers. It helps us build a unique system-of-record for the security and compliance domain that lets companies go beyond certifications and tick-the-box exercises,” says Thomas Regier, co-founder and co-CEO at DataGuard. “This and our comprehensive risk-first approach give DataGuard an asymmetric advantage as we transition into the era of AI-piloted security and compliance programs. We will continue to integrate strategic tech partners natively into our software ecosystem – to further broaden our customer value proposition and expand our geographic footprint.”
“In the era of data and artificial intelligence, organisations are constantly exposed to an increasing number of cyber threats and are required to comply with a multitude of frameworks to continue their business operations. As we know from our customers, ‘the risk is real’, and we believe the best way to address this is to have an effective digital information security and compliance management system. Partnering with DPOrganizer helps us further this mission,” said Kivanc Semen, co-founder and co-CEO at DataGuard.
“DPOrganizer was built for and is loved by privacy and compliance professionals. By joining forces with DataGuard, we can add capabilities such as the AI copilot, asset management, risk and controls management, and numerous information security frameworks. We thereby enable customers to build the bridge between security and compliance, expert and non-expert, business and compliance people. I am beyond excited to start this joint journey and combine our deep domain expertise and technological capabilities. We will continue to give thousands of customers a best-in-class experience,” Egil Bergenlind, co-founder of DPOrganizer summarizes.
About DataGuard
DataGuard is a security and compliance software company trusted by more than 4,000 organisations across the globe. Customers use the platform to build up a scalable risk management and a strong security posture while getting certified fast and complying effortlessly with industry regulation and frameworks such as ISO 27001, TISAX®, NIS2, SOC2, GDPR, and the EU Whistleblower Directive. Our purpose-built software suite offers AI-powered workflow automation and seamless integration capabilities, reducing the time and money organisations spend to build a digital Information Security Management System (ISMS) and Compliance Management System (CMS). DataGuard empowers organisations active in 50+ countries to better understand, identify, and manage the risks that matter most to them – and to build up a robust security and compliance posture that allows them to stay ahead of their evolving business and regulatory needs.
About DPOrganizer
DPOrganizer is a market leading provider of privacy management software that helps privacy professionals in 20+ countries to build more effective and sustainable data protection programs. The company offers an intuitive and easy to use software supporting customers with data mapping, assessment automation, reporting and visualization, data protection trainings, data subject request and incident management.
TISAX® is a registered trademark of the ENX Association. DataGuard is not affiliated with the ENX Association.
We provide Software-as-a-Service and support for the assessment on TISAX® only.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240605633259/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 12:00:00 CEST | Press release
TEVIMBRA plus ZIIHERA and chemotherapy regimen delivered statistically significant median OS of 26.4 months, an unprecedented result in this challenging diseaseResults from the global Phase 3 HERIZON-GEA-01 study demonstrate potential to change clinical practice in advanced HER2+ gastroesophageal adenocarcinoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indica
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 11:30:00 CEST | Press release
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt
Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 10:27:00 CEST | Press release
OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,
The Jury Has Been Announced for the Third Edition of the Reply AI Film Festival, Dedicated to the Best Short Films Generated With Artificial Intelligence29.4.2026 10:00:00 CEST | Press release
Gabriele Salvatores, together with Rob Minkoff, Catherine Hardwicke, Jed Weintrob, Christina Lee Storm, Nils Hartmann, Guillem Martinez Roura, Filippo Rizzante, Giacomo Mineo, Brian Welk and Denise Negri, will judge the short films in competition based on creativity, production quality and the use of Artificial Intelligence. Reply [EXM, STAR: REY], an international group specialized in creating new business models enabled by AI and long committed to guiding younger generations in exploring emerging technologies, presents the jury of the third edition of the Reply AI Film Festival, the international competition aimed at creatives, directors, and filmmakers who want to challenge themselves in producing short films created using Artificial Intelligence tools. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429288361/en/ “Imaginatio Nova” is the theme of the 2026 edition, an invitation to explore a new phase of imagination, wh
Bregal Milestone Announces Majority Growth Investment in CoreGo, a Leading European Open-Loop Payment and Event Technology Company29.4.2026 10:00:00 CEST | Press release
Investment follows over 98% annual growth and supports CoreGo’s continued market expansion Bregal Milestone, a leading European software growth private equity firm, today announced a majority strategic growth investment in CoreGo Oy ("CoreGo" or the "Company"), a leading provider of open-loop payments and integrated technology solutions for festivals, sports events, and venues across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427991105/en/ Founded in Helsinki in 2015 by Hannu Elomaa and CTO Nikoteemu Väänänen, CoreGo has built one of Europe's most differentiated open-loop payment infrastructure and event technology businesses. Serving approximately 250 customers across the Nordics and DACH region, the Company delivers an integrated showtime-critical suite of solutions through CoreGo Cloud, unifying payments, access, networks, and data into a single real-time operating system. CoreGo’s in-house private network
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
